Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification
Miguel D. Ferrer(Universidad de Zaragoza), Joan Perelló(Sanifit (Spain)), Eva Tur(Sanifit (Spain)), Ellen Neven(University of Antwerp), Fernando Tur(Sanifit (Spain)), Markus Ketteler(Robert Bosch Hospital), Geert J. Behets(University of Antwerp), Patrick C. D’Haese(University of Antwerp), Pieter Joubert(King's College London), Carolina Salcedo(Sanifit (Spain)), Bernat Isern(Sanifit (Spain))
Cited by 51
Related Papers
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|Science Translational Medicine|2010|335
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update
|Annals of Internal Medicine|2018|316
Effect of Vitamin K2 Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized Trial
|American Journal of Kidney Diseases|2011|293
Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
|Current Medicinal Chemistry|2018|242